Harvoni 33.75 mg/1
ledipasvir and sofosbuvir · PELLET · Gilead Sciences, Inc
No Recall History
Plain English
Harvoni is a pellet containing ledipasvir and sofosbuvir at 33.75 mg/1, taken oral. Manufactured by Gilead Sciences, Inc.
Key Facts
- Brand Name
- Harvoni
- Generic Name
- ledipasvir and sofosbuvir
- NDC Code (Product)
61958-1805- Manufacturer
- Gilead Sciences, Inc
- Strength
- 33.75 mg/1
- Dosage Form
- PELLET
- Route
- ORAL
- Marketing Status
- Application #
- NDA212477
- Drug Class
- Hepatitis C Virus NS5A Inhibitor [EPC]; Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]
- Marketing Start
- 08/28/2019
Recall History
No Recall HistoryFrequently Asked Questions
What is Harvoni used for?
Harvoni contains ledipasvir and sofosbuvir. It is a pellet taken oral. Consult your doctor for specific uses.
Is Harvoni a controlled substance?
Harvoni is not classified as a controlled substance by the DEA.
What is the generic name for Harvoni?
The generic name for Harvoni is ledipasvir and sofosbuvir. There are 1 other brand versions of ledipasvir and sofosbuvir.
What is the NDC code for Harvoni 33.75 mg/1?
The NDC (National Drug Code) for Harvoni 33.75 mg/1 is 61958-1805, listed by Gilead Sciences, Inc.